title: Remission and time of resolution of nail psoriasis during infliximab therapy.
authors.forename: Luca
authors.initials: L
authors.lastname: Bianchi
authors.forename: Antonio
authors.initials: A
authors.lastname: Bergamin
authors.forename: Catia
authors.initials: C
authors.lastname: de Felice
authors.forename: Elisabetta
authors.initials: E
authors.lastname: Capriotti
authors.forename: Sergio
authors.initials: S
authors.lastname: Chimenti
mesh_terms: D000328:Adult; D000368:Aged; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D006801:Humans; D000069285:Infliximab; D008875:Middle Aged; D009260:Nail Diseases / Q000188:drug therapy* / Q000209:etiology; D011565:Psoriasis / Q000150:complications / Q000188:drug therapy*; D012074:Remission Induction; D013997:Time Factors; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
chemical_list: D000911:Antibodies, Monoclonal; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab